{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:34:19Z","timestamp":1794238459192,"version":"4.9.0"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T00:00:00Z","timestamp":1434326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet. Med."],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>To examine whether women with an HbA<jats:sub>1c<\/jats:sub> of 41\u201349\u00a0mmol\/mol (5.9\u20136.6%) at diagnosis of gestational diabetes are higher risk than women with an HbA<jats:sub>1c<\/jats:sub> of\u00a0&lt;\u00a041\u00a0mmol\/mol (5.9%) and whether pregnancy outcomes are improved if treated at\u00a0&lt;\u00a024\u00a0weeks' gestation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was an observational study of women with gestational diabetes diagnosed by early HbA<jats:sub>1c<\/jats:sub> screening or subsequent oral glucose tolerance test at\u00a0&lt;\u00a034\u00a0weeks' gestation who delivered at National Women's Health, Auckland, from July 2012 to June 2014. Data were extracted from the hospital database. Women with HbA<jats:sub>1c<\/jats:sub> 41\u201349\u00a0mmol\/mol (5.9\u20136.6%) were divided into those seen\u00a0&lt;\u00a024\u00a0weeks (Early, <jats:italic>n<\/jats:italic>\u00a0=\u00a0134) and those seen\u00a0\u2265\u00a024\u00a0weeks (Later, <jats:italic>n<\/jats:italic>\u00a0=\u00a0151). Those with HbA<jats:sub>1c<\/jats:sub>\u00a0&lt;\u00a041\u00a0mmol\/mol (5.9%) were labelled Other <jats:styled-content style=\"fixed-case\">GDM<\/jats:styled-content> (<jats:italic>n<\/jats:italic>\u00a0=\u00a0661).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Early and Later groups, compared with Other <jats:styled-content style=\"fixed-case\">GDM<\/jats:styled-content>, had more Polynesian and fewer (non\u2010Indian) Asian women, higher <jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content> and more required medication (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). More were smokers (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.007, 0.02) and more had chronic hypertension (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001, 0.02). There were higher rates of adverse outcomes in the Later group than the Other <jats:styled-content style=\"fixed-case\">GDM<\/jats:styled-content> group (pre\u2010eclampsia 8.0% vs. 2.4%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.001, preterm birth 16.6% vs. 8.2%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.002, neonatal admission 15.5% vs. 9.2%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.02). Outcomes were similar between the Early group and Other <jats:styled-content style=\"fixed-case\">GDM<\/jats:styled-content> group (pre\u2010eclampsia 1.5% vs. 2.4%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.5, preterm birth 10.5% vs. 8.2% <jats:italic>P<\/jats:italic>\u00a0=\u00a00.4, neonatal admission 13.6% vs. 9.2%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.12). Comparing the Early and Later groups, the Early group had less pre\u2010eclampsia, 1.5% vs. 8.0%, adjusted <jats:italic>P<\/jats:italic>\u00a0=\u00a00.03. Other outcomes were not statistically different.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An HbA<jats:sub>1c<\/jats:sub> of 41\u201349\u00a0mmol\/mol (5.9\u20136.7%) identifies a higher\u2010risk group of women with gestational diabetes. Overall, our data support early treatment of women with an HbA<jats:sub>1c<\/jats:sub>\u00a0\u2265\u00a041\u00a0mmol\/mol (5.9%).<\/jats:p><\/jats:sec>","DOI":"10.1111\/dme.12812","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T17:21:28Z","timestamp":1432920088000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Women with an HbA<sub>1c<\/sub> of 41\u201349\u00a0mmol\/mol (5.9\u20136.6%): a higher risk subgroup that may benefit from early pregnancy intervention"],"prefix":"10.1111","volume":"33","author":[{"given":"J. A.","family":"Rowan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology National Women's Health Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Budden","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology National Women's Health Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology National Women's Health Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology University of Otago Christchurch Women's Hospital Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Sadler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology National Women's Health Auckland New Zealand"},{"name":"Department of Epidemiology and Biostatistics School of Population Health University of Auckland Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00215.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2009.034"},{"key":"e_1_2_8_4_1","first-page":"70","article-title":"Understanding the new HbA1c units for the diagnosis of Type\u00a02 diabetes","volume":"125","author":"Braatvedt GD","year":"2012","journal-title":"NZ Med J"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1312"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2000.tb01137.x"},{"key":"e_1_2_8_7_1","first-page":"905","article-title":"Trimester\u2010specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy","volume":"50","author":"O'Connor C","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1200"},{"key":"e_1_2_8_9_1","first-page":"395","article-title":"Predictors of preeclampsia in women in the metformin in gestational diabetes (MiG) study","volume":"5","author":"Barrett HL","year":"2014","journal-title":"Diabetes Metab"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0244"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042973"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.02.006"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0555"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(03)00661-6"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1407"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12166"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdme.12812","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.12812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:08:40Z","timestamp":1696331320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.12812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1111\/dme.12812"],"URL":"https:\/\/doi.org\/10.1111\/dme.12812","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,15]]},"assertion":[{"value":"2015-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}